Kingdon Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-67,055	Closed	-$824K	–	137
2017 Q3	$824K	Sell	67,055 -539,355	-89%	-$7.96M	0.07%	107
2017 Q2	$9.97M	Sell	606,410 -1,083,863	-64%	-$16.8M	0.86%	50
2017 Q1	$24.2M	Buy	1,690,273 +472,698	+39%	+$7.01M	1.83%	24
2016 Q4	$16.8M	Buy	1,217,575 +407,909	+50%	+$6.54M	1.16%	43
2016 Q3	$14.6M	Buy	809,666 +315,286	+64%	+$5.07M	0.96%	37
2016 Q2	$7.09M	Sell	494,380 -30,000	-6%	-$407K	0.57%	66
2016 Q1	$6.27M	Sell	524,380 -250,000	-32%	-$2.62M	0.49%	67
2015 Q4	$10.3M	Buy	774,380 +249,380	+48%	+$3.07M	0.77%	58
2015 Q3	$5.64M	Buy	+525,000	New	+$5.73M	0.46%	78